Susquehanna International Group’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $978K | Buy |
129,918
+50,480
| +64% | +$380K | ﹤0.01% | 3286 |
|
|
2025
Q1 | $601K | Buy |
79,438
+43,702
| +122% | +$331K | ﹤0.01% | 4101 |
|
|
2024
Q4 | $435K | Buy |
35,736
+2,155
| +6% | +$26.2K | ﹤0.01% | 4269 |
|
|
2024
Q3 | $562K | Buy |
33,581
+18,095
| +117% | +$303K | ﹤0.01% | 3491 |
|
|
2024
Q2 | $270K | Sell |
15,486
-19,129
| -55% | -$334K | ﹤0.01% | 4342 |
|
|
2024
Q1 | $590K | Buy |
34,615
+14,651
| +73% | +$250K | ﹤0.01% | 3318 |
|
|
2023
Q4 | $203K | Buy |
19,964
+7,017
| +54% | +$71.5K | ﹤0.01% | 4990 |
|
|
2023
Q3 | $117K | Sell |
12,947
-9,568
| -42% | -$86.6K | ﹤0.01% | 4854 |
|
|
2023
Q2 | $242K | Buy |
22,515
+1,287
| +6% | +$13.8K | ﹤0.01% | 4451 |
|
|
2023
Q1 | $217K | Buy |
+21,228
| New | +$217K | ﹤0.01% | 4784 |
|
|
2022
Q4 | – | Sell |
-19,775
| Closed | -$254K | – | 5923 |
|
|
2022
Q3 | $254K | Buy |
+19,775
| New | +$254K | ﹤0.01% | 4462 |
|
|
2022
Q2 | – | Sell |
-15,182
| Closed | -$159K | – | 5887 |
|
|
2022
Q1 | $159K | Sell |
15,182
-13,064
| -46% | -$137K | ﹤0.01% | 4955 |
|
|
2021
Q4 | $436K | Buy |
+28,246
| New | +$436K | ﹤0.01% | 3984 |
|